Search Within

Sergio Andres Giralt

Formats
  1. Meeting Abstract (642)
  2. Journal Article (376)
  3. Research Letter (20)
  4. Review (15)
  5. Guidelines (5)
  6. Correspondence (4)
  7. Editorial (4)
  8. Book Section (3)
Groups
  1. Bone Marrow Transplant (1069)
  2. Center for Hematologic Malignancies (1069)
  3. Department of Medicine (1069)
  4. Hematologic Malignancies, Division of (1069)
  5. Survivorship Research (703)
  6. CTCR Scholars (557)

More Groups

People
  1. Miguel-Angel Perales (429)
  2. Sean Devlin (380)
  3. Gunjan Shah (311)
  4. Michael Scordo (279)
  5. Heather Landau (263)
  6. Ann Jakubowski (242)

More People

Years
  1. 2025 (18)
  2. 2024 (65)
  3. 2023 (104)
  4. 2022 (77)
  5. 2021 (66)
  6. 2020 (91)

More Years

Publications
  1. Blood (314)
  2. Biology of Blood and Marrow Transplantation (275)
  3. Bone Marrow Transplantation (80)
  4. Clinical Lymphoma, Myeloma and Leukemia (60)
  5. Journal of Clinical Oncology (40)
  6. Transplantation and Cellular Therapy (36)

More Publications

Publishers
  1. Elsevier Inc. (386)
  2. American Society of Hematology (349)
  3. Nature Publishing Group (110)
  4. American Society of Clinical Oncology (42)
  5. Taylor & Francis Group (35)
  6. Ferrata Storti Foundation (13)

More Publishers

Results (1069)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Standardizing definitions of hematopoietic recovery, graft rejection, graft failure, poor graft function, and donor chimerism in allogeneic hematopoietic cell transplantation: A report on behalf of the American Society for Transplantation and Cellular Therapy
    Guidelines

    Kharfan-Dabaja, M. A.; Kumar, A.; Ayala, E.; Aljurf, M.; Nishihori, T.; Marsh, R.; Burroughs, L. M.; Majhail, N.; Al-Homsi, A. S.; Al-Kadhimi, Z. S.; more...
    Transplantation and Cellular Therapy (2021)

    Fulltext@MSK | Save
  • Reduced-intensity conditioning hematopoietic stem cell transplantation for chronic lymphocytic leukemia and Richter's transformation
    Journal Article

    Lahoud, O. B.; Devlin, S. M.; Maloy, M. A.; Roeker, L. E.; Dahi, P. B.; Ponce, D. M.; Gyurkocza, B.; Koehne, G.; Young, J. W.; Castro-Malaspina, H. R.; more...
    Blood Advances (2021)

    Fulltext@MSK | Save
  • Coast (OP-501): First in man phase I multicenter study evaluating OPD5 as a myeloablative conditioning regimen in relapsed refractory multiple myeloma (RRMM)
    Meeting Abstract

    Giralt, S.; Bäck, K.; Norin, S.; Gay, F.
    Bone Marrow Transplantation (2021)

    Fulltext@MSK | Save
  • Open label dose escalation trial of AB-205 (E-CEL® cells) in adults with systemic lymphoma undergoing high-dose therapy and autologous hematopoietic cell transplantation (HDT-AHCT)
    Meeting Abstract

    Mulroney, C.; Scordo, M.; Abedi, M.; Budde, L. E.; Fakhri, B.; Pawarode, A.; Dholaria, B.; Shouse, G.; Kavalerchik, E.; Aggarwal, S.; more...
    Bone Marrow Transplantation (2021)

    Fulltext@MSK | Save
  • Microbiota injury is conditioning regimen-dependent in allogeneic hematopoietic cell transplantation recipients
    Meeting Abstract

    Shouval, R.; Gomes, A.; Nguyen, C.; Markey, K. A.; Dai, A.; Zuanelli Brambilla, C.; Taur, Y.; Scordo, M.; Giralt, S. A.; Perales, M. A.; more...
    Bone Marrow Transplantation (2021)

    Fulltext@MSK | Save
  • A phase 1, multicenter study evaluating the safety and efficacy of KITE-585, an autologous anti-BCMA CAR T-cell therapy, in patients with relapsed/refractory multiple myeloma
    Journal Article

    Cornell, R. F.; Bishop, M. R.; Kumar, S.; Giralt, S. A.; Nooka, A. K.; Larson, S. M.; Locke, F. L.; Raje, N. S.; Lei, L.; Dong, J. H.; more...
    American Journal of Cancer Research (2021)

    Fulltext@MSK | Save
  • Safety and effectiveness of weekly carfilzomib, lenalidomide, dexamethasone, and daratumumab combination therapy for patients with newly diagnosed multiple myeloma the MANHATTAN nonrandomized clinical trial
    Journal Article

    Landgren, O.; Hultcrantz, M.; Diamond, B.; Lesokhin, A. M.; Mailankody, S.; Hassoun, H.; Tan, C.; Shah, U. A.; Lu, S. X.; Salcedo, M.; more...
    JAMA Oncology (2021)

    Fulltext@MSK | Save
  • Toxicities of high-dose chemotherapy and autologous hematopoietic cell transplantation in older patients with lymphoma
    Journal Article

    Dahi, P. B.; Lee, J.; Devlin, S. M.; Ruiz, J.; Maloy, M.; Rondon-Clavo, C.; Petrlik, E.; Tamari, R.; Shah, G.; Scordo, M.; more...
    Blood Advances (2021)

    Fulltext@MSK | Save
  • Myeloablative versus reduced-intensity conditioning for hematopoietic cell transplantation in acute myelogenous leukemia and myelodysplastic syndromes—Long-term follow-up of the BMT CTN 0901 clinical trial
    Journal Article

    Scott, B. L.; Pasquini, M. C.; Fei, M.; Fraser, R.; Wu, J.; Devine, S. M.; Porter, D. L.; Maziarz, R. T.; Warlick, E.; Fernandez, H. F.; more...
    Transplantation and Cellular Therapy (2021)

    Fulltext@MSK | Save
  • Dynamics of minimal residual disease in patients with multiple myeloma on continuous lenalidomide maintenance: A single-arm, single-centre, phase 2 trial
    Journal Article

    Diamond, B.; Korde, N.; Lesokhin, A. M.; Smith, E. L.; Shah, U.; Mailankody, S.; Hultcrantz, M.; Hassoun, H.; Lu, S. X.; Tan, C.; more...
    The Lancet Haematology (2021)

    Fulltext@MSK | Save